Pfizer Inc., a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1849, Pfizer has established itself as a global powerhouse, with significant operations across North America, Europe, and Asia. The company is renowned for its innovative research and development in areas such as oncology, immunology, and vaccines, including its pivotal role in the COVID-19 pandemic.
With a diverse portfolio of core products, Pfizer offers unique solutions that address critical health challenges, setting it apart in a competitive market. Notable achievements include the rapid development of its mRNA vaccine, which has significantly impacted public health. As a trusted leader in pharmaceuticals, Pfizer continues to advance medical science and improve patient outcomes worldwide.
+61 vs industry average
Pfizer’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Pfizer?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Pfizer's reported carbon emissions
Pfizer, a pharmaceutical preparation manufacturing company based in the US, reported approximately 4.9 billion kg CO2e in total emissions for 2023. This figure is a sum of Scope 1, 2, and 3 emissions.
For the year 2022, Pfizer's total emissions were approximately 10.5 billion kg CO2e. Scope 1 emissions accounted for about 644.6 million kg CO2e, while Scope 2 emissions were approximately 483.3 million kg CO2e (market-based). Scope 3 emissions were significantly higher, totalling around 9.38 billion kg CO2e, with purchased goods and services being the largest contributor within this scope.
Looking at recent years:
- In 2025, projected total emissions are approximately 4.16 billion kg CO2e, comprising Scope 1 at around 614.3 million kg CO2e, Scope 2 at approximately 134.2 million kg CO2e (market-based), and Scope 3 at about 3.41 billion kg CO2e.
- For 2024, total emissions were approximately 4.79 billion kg CO2e. Scope 1 emissions were around 616.8 million kg CO2e, Scope 2 emissions were approximately 513.5 million kg CO2e (market-based), and Scope 3 emissions were approximately 3.56 billion kg CO2e.
Pfizer has established several climate commitments and reduction targets:
- Net-Zero Ambition: Pfizer aims to achieve the Net-Zero standard across its value chain by 2040. This includes a goal to reduce company emissions (Scope 1 and 2) by 95% by 2040 and value chain emissions by 90% from 2019 levels.
- Near-Term Emissions Reduction: Pfizer is committed to reducing its Scope 1 and 2 greenhouse gas (GHG) emissions by 46% by 2030, using a 2019 baseline. This target is aligned with a 1.5°C trajectory and has been approved by the Science Based Targets initiative (SBTi).
- Renewable Electricity: The company aims to increase its annual sourcing of renewable electricity to 100% by 2030.
- Scope 3 Targets: Specific targets for Scope 3 emissions include a commitment to reduce emissions from business travel by 25% by 2025 from a 2019 baseline, and a 10% reduction in emissions from upstream transportation and distribution by 2025 from a 2019 baseline. Additionally, Pfizer aims to have 64% of its suppliers by spend (covering purchased goods and services) set their own science-based GHG reduction targets by 2025.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Pfizer’s Climate Goals (2030 & 2050)
11 goals2040
95% reduction in Scope 2
Net Zero Standard by 2040, ten years earlier than the timeline described in the standard. By 2040 Pfizer aims to decrease its company GHG…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 11 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Pfizer
Frequently asked questions
Common questions about Pfizer’s sustainability data and climate commitments
Data year: 2022
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project